Transaminase
In biochemistry, a transaminase or an aminotransferase is an enzyme that catalyzes a type of reaction between an amino acid and an α-keto acid. They are important in the synthesis of amino acids, which form proteins. In medicine, they are an important indicator of liver damage.
An amino acid contains an amine (NH2) group. A keto acid contains a keto (=O) group. In transamination, the NH2 group on one molecule is exchanged with the =O group on the other molecule. The amino acid becomes a keto acid, and the keto acid becomes an amino acid.
Some transamination activities of the ribosome have been found to be catalyzed by so-called ribozymes (RNA enzymes). Examples being the hammerhead ribozyme, the VS ribozyme and the hairpin ribozyme.
The transaminase enzymes are important in the production of various amino acids, and measuring the concentrations of various transaminases in the blood is important in the diagnosing and tracking many diseases. Transaminases require the coenzyme pyridoxal-phosphate, which is converted into pyridoxamine in the first phase of the reaction, when an amino acid is converted into a keto acid. Enzyme-bound pyridoxamine in turn reacts with pyruvate, oxaloacetate, or alpha-ketoglutarate, giving alanine, aspartic acid, or glutamic acid, respectively. Many transamination reactions occur in tissues, catalysed by transaminases specific for a particular amino/keto acid pair. The reactions are readily reversible, the direction being determined by which of the reactants are in excess. The specific enzymes are named from one of the reactant pairs, for example; the reaction between glutamic acid and pyruvic acid to make alpha ketoglutaric acid and alanine is called glutamic-pyruvic transaminase or GPT for short.
Tissue transaminase activities can be investigated by incubating a homogenate with various amino/keto acid pairs. Transamination is demonstrated if the corresponding new amino acid and keto acid are formed, as revealed by paper chromatography. Reversibility is demonstrated by using the complementary keto/amino acid pair as starting reactants. After chromatogram has been taken out of the solvent the chromatogram is then treated with ninhydrin to locate the spots.
The presence of elevated transaminases can be an indicator of liver and cardiac damage. Two important transaminase enzymes are aspartate transaminase (AST), also known as serum glutamic oxaloacetic transaminase (SGOT); and alanine transaminase (ALT), also called alanine aminotransferase (ALAT) or serum glutamate-pyruvate transaminase (SGPT). The discovery of these transaminases was by Arthur Karmen and colleagues in 1954[1][2][3] and their clinical importance by Fernando De Ritis, Mario Coltorti and Giuseppe Giusti in 1955 at the University of Naples.[4][5][6][7]
Transaminases in amino acid metabolism in animals
Animals must metabolize proteins to amino acids, at the expense of muscle tissue, when blood sugar is low. The preference of liver transaminases for oxaloacetate or alpha-ketoglutarate plays a key role in funneling nitrogen from amino acid metabolism to aspartate and glutamate for conversion to urea for excretion of nitrogen. In similar manner, in muscles the use of pyruvate for transamination gives alanine, which is carried by the bloodstream to the liver (the overall reaction being termed glucose-alanine cycle). Here other transaminases regenerate pyruvate, which provides a valuable precursor for gluconeogenesis. This alanine cycle is analogous to the Cori cycle, which allows anaerobic metabolism by muscles.
See also
- Valproic acid - a GABA transaminase inhibitor
References
- ↑ KARMEN, A; WROBLEWSKI, F; LADUE, JS (January 1955). "Transaminase activity in human blood.". The Journal of Clinical Investigation. 34 (1): 126–31. doi:10.1172/jci103055. PMC 438594
. PMID 13221663. - ↑ KARMEN, A (January 1955). "A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum.". The Journal of Clinical Investigation. 34 (1): 131–3. PMC 438594. PMID 13221664.
- ↑ LADUE, JS; WROBLEWSKI, F; KARMEN, A (24 September 1954). "Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction.". Science. 120 (3117): 497–9. doi:10.1126/science.120.3117.497. PMID 13195683.
- ↑ http://vecchiosito.bnnonline.it/news/serata.htm
- ↑ http://notizie-segreteria-liver-pool.blogspot.it/2009/01/e-morto-il-prof-coltorti-scopr-le.html
- ↑ http://www.istitutobioetica.org/Chi%20siamo/Campania%20su%20Coltorti.htm
- ↑ http://www.ilrestodelcarlino.it/macerata/2009/01/03/142193-morto_mario_coltorti_scopri_transaminasi.shtml
- Ghany, Marc & Hoofnagle, Jay H. (2005). Approach to the Patient With Liver Disease. In Dennis L. Kasper, Anthony S. Fauci, Dan L. Longo, Eugene Braunwald, Stephen L. Hauser, & J. Larry Jameson (Eds.), Harrison's Principles of Internal Medicine (16th Edition), pp. 1814–1815. New York: McGraw-Hill.
- Nelson, David L. & Cox, Michael M. (2000). Lehninger Principles of Biochemistry (3rd ed.), pp. 628–631, 634, 828–830. New York: Worth Publishers.
External links
- Transaminases at the US National Library of Medicine Medical Subject Headings (MeSH)